PHARMACEUTICAL IP

Evolve Insights

Welcome to Evolve Insights!

Evolve Insights is your go-to source for expert analysis and strategic perspectives on pharmaceutical IP.

  • Read our Articles for the latest pharma IP news and analysis. Many of our articles were originally published on IPKat.
  • Register for our upcoming live Webinars and watch our previous webinars on-demand.
  • Subscribe to our newsletter to stay up to date.

Do you have questions about how the latest developments in IP might impact you? Our team of experts would love to hear from you.

Latest articles

All articles

IP strategy for Cell Therapy: FAQs

When do we need a freedom to operate opinion for our cell therapy product? Only once the product is finalised and heading into the clinic. A full opinion on a construct, a formulation and a process that are all still moving will be out of date before it is delivered, so the right moment is…

New referral on claim interpretation and relevance of G1/24 to added matter confirmed (G1/26)

We now have confirmation of a new referral to the EBA on claim interpretation (G1/26). As previously hinted, The Board of Appeal in T 0873/24 has decided to refer questions on the application of G1/24 to the assessment of added matter.

AI in the patent industry: Bubble trouble and the affordability myth

Whenever we write about AI, responses have started to move away from talk about hallucination, confidentiality or quality. The new concern is one of economics, i.e. will the whole AI thing just become too expensive and are we putting ourselves at risk by outsourcing to AI.

Webinars

All webinars
  • On-demand

Unlocking the potential of cell & gene therapies with effective IP strategy

Recorded on: July 11, 2025
Discover how to transform ground-breaking cell & gene therapy science into commercial success with robust IP strategies.

Stay connected

Get the latest insights, news, and expert analysis on pharmaceutical IP delivered straight to your inbox.
Subscribe for updates